SureChEMBL: open patent data for all
In plain English
AI plain-English summaryEvery month, around 80,000 newly patented chemical compounds are extracted and stored in SureChEMBL, a free, open-access database that already holds more than 20 million unique chemical structures from roughly 50 million patents. This matters because most patent data is locked behind paywalls or scattered across incompatible formats, making it difficult for researchers to see what molecules have already been patented before starting their own drug development work. Without open access, scientists waste time and money rediscovering known compounds or inadvertently infringing on existing patents. If this upgrade succeeds, the improved SureChEMBL will let researchers search not just by chemical structure but also by biological targets—such as proteins or genes—and assess how relevant a patent is to their question. A new application programming interface (API) will allow computer programs to query the database automatically, enabling large-scale data mining. The result would be a faster, more reliable way for the global life-sciences community to navigate the patent landscape, reducing duplication of effort and accelerating the early stages of drug discovery. This is infrastructure research: it does not create a new drug itself, but it quietly underpins the entire process of finding one.
View original technical description
View the original record at the funder ↗
Researchers
Related Research
Grants with similar aims, by meaning.
Original classification
Biomedical Resources GrantPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know